MSOS News

January 2022 MSOS Member Briefing
Post date: 1 day 13 hours ago

Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, January 27, 2022 from 1:00-2:00 PM ET.

Register Now: https://ecri.zoom.us/webinar/register/WN_yXOM9MJGTCuZj_XasIjAAg

Short medication safety-related presentations for this webinar will include:

• Safeguards Around Adult Use of Continuously Inhaled Epoprostenol
Sammy Burton, PharmD, FISMP
Cleveland Clinic

• Utilizing the EMR to Assure Safe Paralytic Infusion Practices
Mara Weber, PharmD
OhioHealth

• Multi-Chamber Bag Parenteral Nutrition
Andrew Mays, PharmD
ASPEN PN Safety Committee

• ISMP Update
Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP, President, Institute for Safe Medication Practices

Alert about Paxlovid
Post date: 2 weeks 3 days ago

ISMP has identified possible safety issues with Paxlovid, which was recently authorized for the treatment of COVID-19. Tablets need to be removed from the blister pack for patients with moderate renal impairment. For a copy of ISMP’s special alert with safe practice recommendations, visit: https://www.ismp.org/node/29033

Self Assessment Deadline Extended
Post date: 1 month 1 week ago

Surgery sites now have more time to participate in the ISMP Medication Safety Self Assessment for Perioperative Settings! The data submission deadline has been extended to February 11, 2022. Don’t miss this opportunity to evaluate your medication use systems, identify challenges, and document regulatory compliance. Visit www.ismp.org/node/18027 to access the assessment workbook.

NAN Alert on Vaccine Mix-Ups
Post date: 1 month 1 week ago

ISMP is receiving a steady stream of error reports on age-related mix-ups with the COVID vaccine. A National Alert (NAN) warning has been issued with safe practice recommendations: https://www.ismp.org/node/28619

Multiple Error Pathways with Monoclonal Antibodies
Post date: 2 months 3 days ago

ISMP is receiving reports of confusion and errors with monoclonal antibody products used to treat COVID-19, due to unfamiliar co-packaging and labeling. Read this week’s ISMP newsletter featured article for safe practice recommendations: https://www.ismp.org/node/28457

Pages

read more...